115 related articles for article (PubMed ID: 943577)
1. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
Skinner DG; Dekernion JB; Brower PA; Ramming KP; Pilch YH
J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
[TBL] [Abstract][Full Text] [Related]
2. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
Brower PA; Dekernion JB; Ramming KP
J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
Richie JP; Wang BS; Steele GD; Wilson RE; Mannick JA
J Urol; 1981 Jul; 126(1):24-8. PubMed ID: 6166758
[TBL] [Abstract][Full Text] [Related]
4. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring.
Ramming KP; deKernion JB
Ann Surg; 1977 Oct; 186(4):459-67. PubMed ID: 907390
[TBL] [Abstract][Full Text] [Related]
5. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
[No Abstract] [Full Text] [Related]
6. Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid.
Richie JP; Steele GD; Wilson RE; Ervin T; Wang BS; Mannick JA
J Urol; 1984 Feb; 131(2):236-8. PubMed ID: 6199519
[TBL] [Abstract][Full Text] [Related]
7. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
Veltman LL; Kern DH; Pilch YH
Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321
[No Abstract] [Full Text] [Related]
8. Re: in vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
Bander NH
J Urol; 1982 Apr; 127(4):783. PubMed ID: 6175772
[No Abstract] [Full Text] [Related]
9. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
Dodd MC; Scheetz ME; Rossio JL
Ann N Y Acad Sci; 1973 May; 207():454-67. PubMed ID: 4517721
[No Abstract] [Full Text] [Related]
10. The therapy of renal adenocarcinoma with immune RNA.
deKernion JB; Ramming KP
Invest Urol; 1980 Mar; 17(5):378-81. PubMed ID: 7358501
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for malignant lesions in man using immunogenic ribonucleic acid.
deKernion JB; Ramming KP; Brower P; Skinner DG; Pilch YH
Am J Surg; 1975 Nov; 130(5):575-8. PubMed ID: 1200271
[No Abstract] [Full Text] [Related]
12. Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma.
Steele G; Wang BS; Richie JP; Ervin T; Yankee R; Mannick JA
Cancer; 1981 Mar; 47(6):1286-8. PubMed ID: 6164471
[TBL] [Abstract][Full Text] [Related]
13. Aggressive versus conservative management of stage IV renal cell carcinoma.
Klugo RC; Detmers M; Stiles RE; Talley RW; Cerny JC
J Urol; 1977 Aug; 118(2):244-6. PubMed ID: 894800
[TBL] [Abstract][Full Text] [Related]
14. Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.
Fritze D; Kern DH; Pilch YH
Klin Wochenschr; 1976 Sep; 54(18):851-63. PubMed ID: 787654
[TBL] [Abstract][Full Text] [Related]
15. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
Veltman LL; Kern DH; Pilch YH
Cell Immunol; 1974 Sep; 13(3):367-77. PubMed ID: 4476236
[No Abstract] [Full Text] [Related]
16. Immunological response to tumor ischemia in a murine renal cell carcinoma model.
Edson Pontes J; Goldrosen M; Murphy GP
Oncology; 1983; 40(1):63-6. PubMed ID: 6823406
[No Abstract] [Full Text] [Related]
17. Immunotherapy of renal cell carcinoma.
deKernion JB
Prog Clin Biol Res; 1984; 153():409-21. PubMed ID: 6206509
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypernephroma with xenogeneic immune RNA.
deKernion JB; Ramming KP
Natl Cancer Inst Monogr; 1978 Dec; (49):347-9. PubMed ID: 748792
[TBL] [Abstract][Full Text] [Related]
19. Immune ribonucleic acid (I-RNA) in the treatment of metastatic renal cell carcinoma.
De Vinci C; Pizza G; Severini G; Cuzzocrea D; Corrado F
J Exp Pathol; 1987; 3(4):515-23. PubMed ID: 2457666
[No Abstract] [Full Text] [Related]
20. Experimental and clinical studies on toxicity of xenogeneic tumor-specific immune ribonucleic acid.
Fukushima M; Fukuda S; Machida S; Ishikawa Y
Tohoku J Exp Med; 1979 Jul; 128(3):285-93. PubMed ID: 494251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
